Boothbay Fund Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,688
| Closed | -$504K | – | 1610 |
|
|
2023
Q1 | $504K | Sell |
1,688
-1,465
| -46% | -$437K | 0.01% | 1048 |
|
|
2022
Q4 | $1.08M | Buy |
+3,153
| New | +$1.08M | 0.03% | 703 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1993 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1908 |
|
|
2021
Q3 | – | Sell |
-449
| Closed | -$209K | – | 1667 |
|
|
2021
Q2 | $209K | Buy |
+449
| New | +$209K | 0.01% | 1330 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1319 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1085 |
|
|
2020
Q3 | – | Sell |
-2,054
| Closed | -$1.74M | – | 930 |
|
|
2020
Q2 | $1.74M | Sell |
2,054
-3,268
| -61% | -$2.77M | 0.12% | 191 |
|
|
2020
Q1 | $1.9M | Buy |
5,322
+3,681
| +224% | +$1.32M | 0.16% | 135 |
|
|
2019
Q4 | $384K | Buy |
+1,641
| New | +$384K | 0.03% | 467 |
|